DIOSynVax

News

An AI-powered universal vaccine tech developed by UK biotech DIOSynVax has shown preliminary efficacy in a world-first human trial.

News

Cell therapy developer Legend Biotech has named Ingrid Zhang as its new chief executive, ending its search for new leadership.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.